The 17th World Conference on Lung Cancer (WCLC) took take place on 4–7 December 2016 at the Messe Wien Exhibition & Congress Center, Vienna, Austria. WCLC was presented by the International Association for the Study of Lung Cancer (IASLC).
Boheringer Ingelheim presented Phase II findings from the first-line LUME-Meso trial for the first time at this meeting. Two additional oral presentations covered the overall survival analysis of the LUX-Lung 7 trial and the analysis of long-term responders in the LUX-Lung 8 trial. A further four posters were presented during the poster display session. For more details, please see below.
Independent Medical education
In addition, there was an independent medical education event entitled ‘Reaching new heights in the management of Non-Small Cell Lung Cancer: focus on EGFR-targeted therapy’. The meeting slides can be found here.
Relevant oral and poster presentations,
Wednesday 7th December 2016
The book of abstracts is now accessible here